We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+11.68%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$51B
AUM Growth
+$4.88B
(+11%)
Cap. Flow
+$834M
Cap. Flow
% of AUM
1.63%
Top 10 Holdings %
Top 10 Hldgs %
25.68%
Holding
986
New
26
Increased
432
Reduced
416
Closed
39
Avg Time Held
4.6
years
Top 10 Avg Time Held
3.2
years
Top 20 Avg Time Held
2.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kaspi.kz JSC
KSPI
|
+$260M |
| 2 |
Microsoft
MSFT
|
+$71.2M |
| 3 |
Cardinal Health
CAH
|
+$61.4M |
| 4 |
Clorox
CLX
|
+$47.7M |
| 5 |
Accenture
ACN
|
+$46.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sociedad Química y Minera de Chile
SQM
|
+$63.6M |
| 2 |
Splunk Inc
SPLK
|
+$56.2M |
| 3 |
L3Harris
LHX
|
+$46.8M |
| 4 |
Crown Holdings
CCK
|
+$43M |
| 5 |
Fomento Económico Mexicano
FMX
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.39% |
| 2 | Healthcare | 17.34% |
| 3 | Financials | 11.02% |
| 4 | Consumer Discretionary | 9.2% |
| 5 | Industrials | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
801
Arcutis Biotherapeutics
ARQT
$3.57B
| $1.48M | ﹤0.01% |
148,874
| – | – |
2023 Q4
1 quarter
|
|
802
Takeda Pharmaceutical
TAK
$62.7B
| $1.46M | ﹤0.01% |
105,073
| – | – |
2023 Q4
1 quarter
|
|
803
Perrigo
PRGO
$2.29B
| $1.42M | ﹤0.01% |
44,174
| – | – |
2023 Q4
1 quarter
|
|
804
Jabil
JBL
$29.2B
| $1.39M | ﹤0.01% |
10,343
-802
| -7% | -$108K |
2023 Q3
2 quarters
|
|
805
Xenon Pharmaceuticals
XENE
$3.25B
| $1.38M | ﹤0.01% |
32,036
| – | – |
2023 Q4
1 quarter
|
|
806
JinkoSolar
JKS
$432M
| $1.35M | ﹤0.01% |
53,602
+31,009
| +137% | +$852K |
2022 Q1
8 quarters
|
|
807
Dentsply Sirona
XRAY
$1.74B
| $1.34M | ﹤0.01% |
40,512
-70,982
| -64% | -$2.43M |
2017 Q3
26 quarters
|
|
808
GlobalFoundries
GFS
$26.2B
| $1.33M | ﹤0.01% |
25,453
-551
| -2% | -$30.2K |
2022 Q3
6 quarters
|
|
809
Ralph Lauren
RL
$23B
| $1.32M | ﹤0.01% |
7,030
-243
| -3% | -$40.2K |
2017 Q3
26 quarters
|
|
810
Mohawk Industries
MHK
$8.35B
| $1.31M | ﹤0.01% |
10,017
-187
| -2% | -$21K |
2017 Q3
26 quarters
|
|
811
Liberty Global Class C
LBTYK
$2.66B
| $1.28M | ﹤0.01% |
72,759
-8,714
| -11% | -$168K |
2017 Q3
26 quarters
|
|
812
Performance Food Group
PFGC
$15.3B
| $1.28M | ﹤0.01% |
17,161
-723
| -4% | -$53.2K |
2023 Q2
3 quarters
|
|
813
GDS Holdings
GDS
$4.66B
| $1.28M | ﹤0.01% |
192,600
-408
| -0.2% | -$2.76K |
2019 Q4
17 quarters
|
|
814
First Industrial Realty Trust
FR
$7.82B
| $1.27M | ﹤0.01% |
24,135
-1,210
| -5% | -$63.9K |
2020 Q3
14 quarters
|
|
815
News Corp Class B
NWS
$17.8B
| $1.25M | ﹤0.01% |
46,174
-1,104
| -2% | -$29.2K |
2017 Q3
26 quarters
|
|
816
Waste Connections
WCN
$41.6B
| $1.25M | ﹤0.01% |
7,247
-595
| -8% | -$95.6K |
2018 Q2
23 quarters
|
|
817
EQT Corp
EQT
$33.8B
| $1.22M | ﹤0.01% |
32,900
-2,466
| -7% | -$88.3K |
2022 Q2
7 quarters
|
|
818
DELISTED
Sage Therapeutics
SAGE
| $1.21M | ﹤0.01% |
64,801
| – | – |
2023 Q4
1 quarter
|
|
819
Ryman Hospitality Properties
RHP
$8.77B
| $1.18M | ﹤0.01% |
10,190
-507
| -5% | -$58.2K |
2020 Q4
13 quarters
|
|
820
National Health Investors
NHI
$3.25B
| $1.14M | ﹤0.01% |
18,076
+408
| +2% | +$23K |
2021 Q1
12 quarters
|
|
821
Tapestry
TPR
$23.9B
| $1.12M | ﹤0.01% |
23,566
+6,196
| +36% | +$266K |
2017 Q3
26 quarters
|
|
822
JD.com
JD
$36.5B
| $1.08M | ﹤0.01% |
39,561
-13,983
| -26% | -$342K |
2017 Q3
26 quarters
|
|
|
IGR
823
CBRE Global Real Estate Income Fund
IGR
$573M
| $1.04M | ﹤0.01% |
64,349
| – | – |
2023 Q2
3 quarters
|
|
824
Kanzhun
BZ
$7.25B
| $1.03M | ﹤0.01% |
58,814
+758
| +1% | +$12K |
2022 Q2
7 quarters
|
|
825
Canadian Solar
CSIQ
$687M
| $1.03M | ﹤0.01% |
52,147
+23,293
| +81% | +$502K |
2020 Q1
16 quarters
|
|
Similar funds
Aberdeen Group's Q1 2024 Portfolio in Review
As of Q1 2024, Aberdeen Group held 986 positions worth $51B, up 11% from $46.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Aberdeen Group's Q1 2024 filing shows 26 new, 432 increased, 416 reduced and 39 closed positions. Its largest new stake was Kaspi.kz JSC: 2,541,596 shares worth $327M. The largest sale was Sociedad Química y Minera de Chile, an estimated $63.6M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- Aberdeen Group's largest Q1 2024 buy was Kaspi.kz JSC: 2,541,596 shares worth $327M.
- Aberdeen Group added most to Microsoft in Q1 2024, an estimated $71.2M increase.
- Aberdeen Group's biggest Q1 2024 reduction was Sociedad Química y Minera de Chile, cutting an estimated $63.6M.
- Aberdeen Group fully exited Splunk Inc in Q1 2024, selling an estimated $56.2M.
- Aberdeen Group's ten largest holdings make up 26% of its $51B portfolio in Q1 2024.
- Aberdeen Group opened 26 new positions and closed 39 in Q1 2024.
- Aberdeen Group's portfolio value rose 11% quarter-over-quarter to $51B.
Based on Aberdeen Group's 13F filing for Q1 2024, filed 9 May 2024.